BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16394135)

  • 21. Aberrant promoter methylation and silencing of laminin-5-encoding genes in breast carcinoma.
    Sathyanarayana UG; Padar A; Huang CX; Suzuki M; Shigematsu H; Bekele BN; Gazdar AF
    Clin Cancer Res; 2003 Dec; 9(17):6389-94. PubMed ID: 14695139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.
    Yamashita S; Takahashi S; McDonell N; Watanabe N; Niwa T; Hosoya K; Tsujino Y; Shirai T; Ushijima T
    Cancer Res; 2008 Apr; 68(7):2112-21. PubMed ID: 18381416
    [TBL] [Abstract][Full Text] [Related]  

  • 23. STAT3 acetylation-induced promoter methylation is associated with downregulation of the ARHI tumor-suppressor gene in ovarian cancer.
    Li J; Cui G; Sun L; Wang SJ; Li YL; Meng YG; Guan Z; Fan WS; Li LA; Yang YZ; You YQ; Fu XY; Yan ZF; Huang K
    Oncol Rep; 2013 Jul; 30(1):165-70. PubMed ID: 23604529
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insensitivity to transforming growth factor-beta results from promoter methylation of cognate receptors in human prostate cancer cells (LNCaP).
    Zhang Q; Rubenstein JN; Jang TL; Pins M; Javonovic B; Yang X; Kim SJ; Park I; Lee C
    Mol Endocrinol; 2005 Sep; 19(9):2390-9. PubMed ID: 15905358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chromosome-wide mapping of DNA methylation patterns in normal and malignant prostate cells reveals pervasive methylation of gene-associated and conserved intergenic sequences.
    Yegnasubramanian S; Wu Z; Haffner MC; Esopi D; Aryee MJ; Badrinath R; He TL; Morgan JD; Carvalho B; Zheng Q; De Marzo AM; Irizarry RA; Nelson WG
    BMC Genomics; 2011 Jun; 12():313. PubMed ID: 21669002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant methylation and silencing of ARHI, an imprinted tumor suppressor gene in which the function is lost in breast cancers.
    Yuan J; Luo RZ; Fujii S; Wang L; Hu W; Andreeff M; Pan Y; Kadota M; Oshimura M; Sahin AA; Issa JP; Bast RC; Yu Y
    Cancer Res; 2003 Jul; 63(14):4174-80. PubMed ID: 12874023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNA methylation-based chromatin compartments and ChIP-seq profiles reveal transcriptional drivers of prostate carcinogenesis.
    Simmonds P; Loomis E; Curry E
    Genome Med; 2017 Jun; 9(1):54. PubMed ID: 28592290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genome-wide promoter analysis uncovers portions of the cancer methylome.
    Hoque MO; Kim MS; Ostrow KL; Liu J; Wisman GB; Park HL; Poeta ML; Jeronimo C; Henrique R; Lendvai A; Schuuring E; Begum S; Rosenbaum E; Ongenaert M; Yamashita K; Califano J; Westra W; van der Zee AG; Van Criekinge W; Sidransky D
    Cancer Res; 2008 Apr; 68(8):2661-70. PubMed ID: 18413733
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methylome analysis reveals alterations in DNA methylation in the regulatory regions of left ventricle development genes in human dilated cardiomyopathy.
    Jo BS; Koh IU; Bae JB; Yu HY; Jeon ES; Lee HY; Kim JJ; Choi M; Choi SS
    Genomics; 2016 Aug; 108(2):84-92. PubMed ID: 27417303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A common promoter hypomethylation signature in invasive breast, liver and prostate cancer cell lines reveals novel targets involved in cancer invasiveness.
    Cheishvili D; Stefanska B; Yi C; Li CC; Yu P; Arakelian A; Tanvir I; Khan HA; Rabbani S; Szyf M
    Oncotarget; 2015 Oct; 6(32):33253-68. PubMed ID: 26427334
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decoding the regulatory landscape of medulloblastoma using DNA methylation sequencing.
    Hovestadt V; Jones DT; Picelli S; Wang W; Kool M; Northcott PA; Sultan M; Stachurski K; Ryzhova M; Warnatz HJ; Ralser M; Brun S; Bunt J; Jäger N; Kleinheinz K; Erkek S; Weber UD; Bartholomae CC; von Kalle C; Lawerenz C; Eils J; Koster J; Versteeg R; Milde T; Witt O; Schmidt S; Wolf S; Pietsch T; Rutkowski S; Scheurlen W; Taylor MD; Brors B; Felsberg J; Reifenberger G; Borkhardt A; Lehrach H; Wechsler-Reya RJ; Eils R; Yaspo ML; Landgraf P; Korshunov A; Zapatka M; Radlwimmer B; Pfister SM; Lichter P
    Nature; 2014 Jun; 510(7506):537-41. PubMed ID: 24847876
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An investigation of the potential for epigenetic inactivation by transcription read-through in a sporadic colorectal cancer.
    Srivastava S; Ludwig AK; Wong JWH; Hesson LB
    Gene; 2016 Jul; 585(1):154-158. PubMed ID: 27016300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CrossHub: a tool for multi-way analysis of The Cancer Genome Atlas (TCGA) in the context of gene expression regulation mechanisms.
    Krasnov GS; Dmitriev AA; Melnikova NV; Zaretsky AR; Nasedkina TV; Zasedatelev AS; Senchenko VN; Kudryavtseva AV
    Nucleic Acids Res; 2016 Apr; 44(7):e62. PubMed ID: 26773058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inferring regulatory element landscapes and transcription factor networks from cancer methylomes.
    Yao L; Shen H; Laird PW; Farnham PJ; Berman BP
    Genome Biol; 2015 May; 16(1):105. PubMed ID: 25994056
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dynamic interplay between locus-specific DNA methylation and hydroxymethylation regulates distinct biological pathways in prostate carcinogenesis.
    Kamdar SN; Ho LT; Kron KJ; Isserlin R; van der Kwast T; Zlotta AR; Fleshner NE; Bader G; Bapat B
    Clin Epigenetics; 2016; 8():32. PubMed ID: 26981160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of differentially methylated gene promoters in failing and nonfailing human left ventricle myocardium using computation analysis.
    Koczor CA; Lee EK; Torres RA; Boyd A; Vega JD; Uppal K; Yuan F; Fields EJ; Samarel AM; Lewis W
    Physiol Genomics; 2013 Jul; 45(14):597-605. PubMed ID: 23695888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genomic approaches that aid in the identification of transcription factor target genes.
    Kirmizis A; Farnham PJ
    Exp Biol Med (Maywood); 2004 Sep; 229(8):705-21. PubMed ID: 15337825
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Target gene identification from expression array data by promoter analysis.
    Werner T
    Biomol Eng; 2001 Mar; 17(3):87-94. PubMed ID: 11222983
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines.
    Shann YJ; Cheng C; Chiao CH; Chen DT; Li PH; Hsu MT
    Genome Res; 2008 May; 18(5):791-801. PubMed ID: 18256232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of the interplay between methylation and expression reveals its potential role in cancer aetiology.
    Ozer B; Sezerman U
    Funct Integr Genomics; 2017 Jan; 17(1):53-68. PubMed ID: 27819121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.